Product Images Eptifibatide

This is a chart showing the percentage of patients who experienced events over time (in days) during a treatment with Eptifibatide versus a placebo. The numbers 10, 12, 14, 16, and 18 represent the percentage of patients who experienced events at those specific time points in days.*

This is a description of a medication that comes in a single-dose vial for intravenous use only. The medication has a NDC code of 7012110021 and is manufactured by Gland Pharma Limited. The storage temperature is recommended to be between 20-25°C to prevent degradation. The medication should be protected from light and kept in a controlled room. It is distributed by Amneal Pharmaceuticals and has a reference number of LAB-018996.01.*

This text describes the medication Eptifibatide Injection, which is intended for intravenous use only. It is a single-dose vial containing 20mg/1(2 mg/mL) of the drug, with instructions to discard any unused portion. The usual dose is to be found in the accompanying package insert. Storage instructions include refrigeration at 2° to 8°C (36° to 46°F) until used, and discarding if not used within 2 months of transfer to a controlled room temperature. The manufacturer is Gland Pharma Limited, Hyderabad, India and it is distributed by Amneal Pharmaceuticals LLC, Bridgewater, NJ 08807. Mig.Lic. No. 103/AP/RR/S7/F/R is also mentioned.*

This is a pharmaceutical product with NDC 70121-1003-1 containing 0.75 mg epifvatide and 6.25 mg E Ptlfi batld e citrc acid in water for injection with a pH adjusted with sodium o 3 yGroride to pH 5.5. It is intended for intravenous use only and comes in a single-dose vial. The usual dose can be found in the accompanying package insert. This product should be stored at 2-8°C (36-46°F) but can be transferred to 20-25°C (68-77°F) for up to 2 months. It should be protected from light until administration. The manufacturer is Gland Pharma Limited in Hyderabad-500 043, INDIA and it is distributed by Amneal Pharmaceuticals LLC in Bridgewater, NJ 08807.*

This appears to be a label for a medication called Eptifibatide Injection. The injection is a single dose vial for intravenous use only, and should be discarded if the unused portion is not used within 2 months of transfer. The usual dose is provided in an accompanying package insert. The label also includes manufacturing and distribution information.*